Rinn Law Library
- Research Handbook on Intellectual Property and Climate Change (J.D. Sarnoff ed., Edward Elgar Press, forthcoming 2013)
- The Current State of Patent Eligibility of Medical and Biotechnological Inventions in the United States, in Intellectual Property and Emerging Technologies (Matthew Rimmer & Allison McLennan eds., Edward Elgar Press, 2012)
Full text via SSRN
- Lessons from the United States in Regard to the Recent, More Flexible Application of Injunctive Relief, in Research Handbook on the Interpretation and Enforcement of Intellectual Property under WTO Rules (Carlos Correa ed., Edward Elgar Publishing, 2010)
Full text via Google Books
- With Claudia Chamas and Ben Prickril, Intellectual Property and Medicine: Toward Global Health Equity, in Intellectual Property and Human Development: Current Trends and Future Scenarios (Tzen Wong & Graham Dutfield, eds., Cambridge 2010)
- Government Choices in Innovation Funding (with Reference to Climate Change), 62 Emory L.J. 1087 (2013)
Full text via Emory University
- Patent Eligible Medical and Biotechnology Inventions After Bilski, Prometheus, and Myriad, 19 Texas Intell. Prop. L.J. 392 (2011).
Full text via SSRN
Full text via Hein Online,
DePaul Campus Connect login required off-campus
- With Jonathan Masur, Matthew Sag, & Daniel Williams, The Patenting of Social Interactions: Bilski Before the Supreme Court, 8 Nw J. T & Intell. Prop. 376 (2010)
Full text via Northwestern
- With Sarah Lenz Lock et al., Brief Amicus Curiae in Support of Petitioner, Laboratory Corp. Of America Holdings V. Metabolite Laboratories, Inc., 546 U.S. 975 (2005) (No. 04-607).
- Government Innovation Choices after Rio + 20 and the Need for Further Study, IP Osgoode (July 2, 2012)
Full text via IP Osgoode
- With Lori Andrews, Brief for American Medical Association, American Society of Human Genetics, American College of Obstetricians and Gynecologists, American College of Embryology, and the Medical Society of the State of New York as Amici Curiae in Support of Plaintiffs-Appellees and Arguing for Affirmance, Association for Molecular Pathology V. U.S. Patent and Trademark Office, 689 F.3d 1303 (Fed. Cir. 2012) (No. 2010–1406).
- With Lori Andrews and Amy L. Katz, Brief for Amici Curiae American Medical Association, American Society of Human Genetics, American College of Obstetricians and Gynecologists, American College of Embryology, and the Medical Society of the State of New York in Support of Plaintiffs’ Opposition to Defendants’ Motion to Dismiss and in Support of Plaintiffs’ Motion for Summary Judgment, Association for Molecular Pathology v. U.S. Patent and Trademark Office, 702 F.Supp.2d 181 (S.D.N.Y. 2010) (09 Civ. 4515).
- With Carlos M. Correa, Analysis of Options for Implementing Disclosure of Origin Requirements in Intellectual Property Applications, a Contribution to UNCTAD's Response to the Invitation of the Seventh Conference of the Parties of The Convention on Biological Diversity, UNCTAD/DITC/TED/2004/14 (2006).
Full Text via United Nations Conference on Trade and Development